Nuwellis, Inc. (NUWE)
USD 0.96
(-4.0%)
USD 0.96
(-4.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -17.63 Million USD | -2.67% |
| 2022 | -17.17 Million USD | 12.06% |
| 2021 | -19.52 Million USD | -14.67% |
| 2020 | -17.02 Million USD | 5.95% |
| 2019 | -18.1 Million USD | -6.28% |
| 2018 | -17.03 Million USD | -15.01% |
| 2017 | -14.81 Million USD | 5.43% |
| 2016 | -15.66 Million USD | 39.66% |
| 2015 | -25.95 Million USD | -0.66% |
| 2014 | -25.78 Million USD | -12.75% |
| 2013 | -22.87 Million USD | -53.82% |
| 2012 | -14.86 Million USD | 10.22% |
| 2011 | -16.56 Million USD | -166.29% |
| 2010 | -6.21 Million USD | 7.92% |
| 2009 | -6.75 Million USD | 27.51% |
| 2008 | -9.31 Million USD | 4.81% |
| 2007 | -9.78 Million USD | -80.06% |
| 2006 | -5.43 Million USD | -43.31% |
| 2005 | -3.79 Million USD | -216.14% |
| 2004 | -1.19 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | -2.32 Million USD | 51.15% |
| 2024 Q1 | -4.74 Million USD | -32.17% |
| 2023 Q4 | -3.59 Million USD | -13.56% |
| 2023 Q3 | -3.16 Million USD | 37.0% |
| 2023 FY | -17.63 Million USD | -2.67% |
| 2023 Q1 | -5.85 Million USD | -29.05% |
| 2023 Q2 | -5.02 Million USD | 14.17% |
| 2022 Q1 | -4.41 Million USD | -1.96% |
| 2022 Q2 | -4.3 Million USD | 2.6% |
| 2022 FY | -17.17 Million USD | 12.06% |
| 2022 Q4 | -4.53 Million USD | -15.66% |
| 2022 Q3 | -3.92 Million USD | 8.86% |
| 2021 Q3 | -5.25 Million USD | -11.11% |
| 2021 FY | -19.52 Million USD | -14.67% |
| 2021 Q2 | -4.72 Million USD | 9.43% |
| 2021 Q1 | -5.21 Million USD | -21.8% |
| 2021 Q4 | -4.33 Million USD | 17.52% |
| 2020 FY | -17.02 Million USD | 5.95% |
| 2020 Q1 | -4.56 Million USD | -2.72% |
| 2020 Q2 | -3.92 Million USD | 14.17% |
| 2020 Q3 | -4.25 Million USD | -8.6% |
| 2020 Q4 | -4.28 Million USD | -0.63% |
| 2019 Q2 | -4.42 Million USD | 6.29% |
| 2019 Q1 | -4.72 Million USD | -11.1% |
| 2019 FY | -18.1 Million USD | -6.28% |
| 2019 Q4 | -4.44 Million USD | 1.35% |
| 2019 Q3 | -4.5 Million USD | -1.78% |
| 2018 Q4 | -4.25 Million USD | -0.07% |
| 2018 Q3 | -4.25 Million USD | -1.7% |
| 2018 Q2 | -4.17 Million USD | 4.02% |
| 2018 Q1 | -4.35 Million USD | 39.04% |
| 2018 FY | -17.03 Million USD | -15.01% |
| 2017 FY | -14.81 Million USD | 5.43% |
| 2017 Q4 | -7.14 Million USD | -149.46% |
| 2017 Q3 | -2.86 Million USD | -14.57% |
| 2017 Q2 | -2.49 Million USD | -8.28% |
| 2017 Q1 | -2.3 Million USD | 24.65% |
| 2016 FY | -15.66 Million USD | 39.66% |
| 2016 Q4 | -3.06 Million USD | 24.59% |
| 2016 Q1 | -4.55 Million USD | 28.31% |
| 2016 Q3 | -4.06 Million USD | -2.01% |
| 2016 Q2 | -3.98 Million USD | 12.58% |
| 2015 FY | -25.95 Million USD | -0.66% |
| 2015 Q2 | -6.33 Million USD | 9.34% |
| 2015 Q3 | -6.27 Million USD | 1.04% |
| 2015 Q4 | -6.35 Million USD | -1.29% |
| 2015 Q1 | -6.99 Million USD | -5.05% |
| 2014 Q3 | -6.11 Million USD | 8.2% |
| 2014 Q2 | -6.65 Million USD | -4.57% |
| 2014 FY | -25.78 Million USD | -12.75% |
| 2014 Q4 | -6.65 Million USD | -8.94% |
| 2014 Q1 | -6.36 Million USD | 9.01% |
| 2013 Q3 | -6.17 Million USD | -16.49% |
| 2013 Q4 | -6.99 Million USD | -13.3% |
| 2013 FY | -22.87 Million USD | -53.82% |
| 2013 Q2 | -5.3 Million USD | -20.4% |
| 2013 Q1 | -4.4 Million USD | -7.1% |
| 2012 Q3 | -3.29 Million USD | 1.76% |
| 2012 Q2 | -3.35 Million USD | 18.27% |
| 2012 Q4 | -4.11 Million USD | -24.66% |
| 2012 FY | -14.86 Million USD | 10.22% |
| 2012 Q1 | -4.1 Million USD | 23.11% |
| 2011 Q4 | -5.34 Million USD | -23.9% |
| 2011 FY | -16.56 Million USD | -166.29% |
| 2011 Q3 | -4.31 Million USD | 0.0% |
| 2010 FY | -6.21 Million USD | 7.92% |
| 2009 FY | -6.75 Million USD | 27.51% |
| 2008 FY | -9.31 Million USD | 4.81% |
| 2007 FY | -9.78 Million USD | -80.06% |
| 2006 FY | -5.43 Million USD | -43.31% |
| 2005 FY | -3.79 Million USD | -216.14% |
| 2004 FY | -1.19 Million USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Acutus Medical, Inc. | -14.36 Million USD | -22.763% |
| Cerus Corporation | -30.05 Million USD | 41.337% |
| OrthoPediatrics Corp. | -25.76 Million USD | 31.576% |
| PetVivo Holdings, Inc. | -10.62 Million USD | -65.987% |
| Talis Biomedical Corporation | -66.81 Million USD | 73.614% |
| Vivos Therapeutics, Inc. | -17.29 Million USD | -1.931% |
| Inogen, Inc. | -109.38 Million USD | 83.883% |
| Spectral AI, Inc. | -12.98 Million USD | -35.783% |
| Nano-X Imaging Ltd. | -62.58 Million USD | 71.832% |
| CVRx, Inc. | -43.1 Million USD | 59.098% |
| DIH Holding US, Inc. Warrants | -3.52 Million USD | -399.717% |
| Helius Medical Technologies, Inc. | -12.42 Million USD | -41.857% |
| Orthofix Medical Inc. | -139.11 Million USD | 87.327% |
| Venus Concept Inc. | -28.3 Million USD | 37.723% |
| Accelerate Diagnostics, Inc. | -54.02 Million USD | 67.369% |
| Bioventus Inc. | -81.72 Million USD | 78.428% |
| BrainsWay Ltd. | -4.92 Million USD | -257.824% |
| Envoy Medical, Inc. | -18.37 Million USD | 4.034% |
| electroCore, Inc. | -18.8 Million USD | 6.248% |
| IceCure Medical Ltd | -15.57 Million USD | -13.187% |
| Lucid Diagnostics Inc. | -48.48 Million USD | 63.636% |
| Monogram Orthopaedics, Inc. | -17.26 Million USD | -2.096% |
| MaxCyte, Inc. | -48.29 Million USD | 63.498% |
| NeuroOne Medical Technologies Corporation | -11.95 Million USD | -47.467% |
| Nexalin Technology, Inc. | -5.69 Million USD | -209.499% |
| PAVmed Inc | -68.79 Million USD | 74.373% |
| Rapid Micro Biosystems, Inc. | -56.56 Million USD | 68.831% |
| RxSight, Inc. | -50.08 Million USD | 64.8% |
| Sight Sciences, Inc. | -57.27 Million USD | 69.218% |
| SI-BONE, Inc. | -46.93 Million USD | 62.434% |
| TELA Bio, Inc. | -44.07 Million USD | 60.0% |
| TriSalus Life Sciences, Inc. | -54.15 Million USD | 67.442% |
| Treace Medical Concepts, Inc. | -51.42 Million USD | 65.719% |
| LivaNova PLC | -68.49 Million USD | 74.262% |
| 908 Devices Inc. | -42.75 Million USD | 58.768% |
| Alphatec Holdings, Inc. | -173.39 Million USD | 89.832% |
| Nemaura Medical Inc. | -9.59 Million USD | -83.737% |
| NeuroPace, Inc. | -27.17 Million USD | 35.122% |
| LENSAR, Inc. | -12.22 Million USD | -44.166% |
| Apyx Medical Corporation | -17.25 Million USD | -2.15% |
| Cutera, Inc. | -156.23 Million USD | 88.715% |
| STRATA Skin Sciences, Inc. | -8.6 Million USD | -104.905% |
| BioSig Technologies, Inc. | -28.51 Million USD | 38.166% |
| Anika Therapeutics, Inc. | -87.63 Million USD | 79.883% |
| ClearPoint Neuro, Inc. | -22.44 Million USD | 21.456% |
| Integra LifeSciences Holdings Corporation | 111.52 Million USD | 115.808% |
| Axonics, Inc. | -26.05 Million USD | 32.341% |
| Outset Medical, Inc. | -169.77 Million USD | 89.615% |
| IRIDEX Corporation | -10 Million USD | -76.177% |
| PROCEPT BioRobotics Corporation | -109.17 Million USD | 83.851% |
| IRadimed Corporation | 20.03 Million USD | 187.994% |
| Tivic Health Systems, Inc. | -8.24 Million USD | -113.827% |
| INVO Bioscience, Inc. | -6.76 Million USD | -160.523% |
| Telesis Bio, Inc. | -35.15 Million USD | 49.844% |
| Viemed Healthcare, Inc. | 14.33 Million USD | 223.029% |
| Varex Imaging Corporation | 32.1 Million USD | 154.922% |
| Quipt Home Medical Corp. | 3.91 Million USD | 549.86% |
| Inspira Technologies Oxy B.H.N. Ltd. | -12.13 Million USD | -45.306% |
| Pulmonx Corporation | -61.93 Million USD | 71.535% |
| Dynatronics Corporation | -2.27 Million USD | -675.611% |
| Modular Medical, Inc. | -17.52 Million USD | -0.576% |
| ReShape Lifesciences Inc. | -14.63 Million USD | -20.432% |
| Semler Scientific, Inc. | 22.25 Million USD | 179.215% |
| InMode Ltd. | 195.66 Million USD | 109.011% |
| Bruker Corporation | 436.9 Million USD | 104.035% |
| Cytosorbents Corporation | -31.2 Million USD | 43.51% |
| DexCom, Inc. | 597.7 Million USD | 102.95% |
| Align Technology, Inc. | 643.33 Million USD | 102.74% |
| Viveve Medical, Inc. | -21.55 Million USD | 18.202% |
| ZimVie Inc. | -30.93 Million USD | 43.017% |
| Movano Inc. | -29.69 Million USD | 40.62% |
| Cytek Biosciences, Inc. | -27.84 Million USD | 36.685% |
| Nexalin Technology, Inc. | -5.69 Million USD | -209.499% |
| DIH Holdings US, Inc. Class A Common Stock | -3.52 Million USD | -399.717% |
| Tandem Diabetes Care, Inc. | -233.23 Million USD | 92.441% |
| Profound Medical Corp. | -28.61 Million USD | 38.391% |
| Insulet Corporation | 220 Million USD | 108.014% |
| enVVeno Medical Corporation | -25.23 Million USD | 30.145% |
| Surmodics, Inc. | -5.64 Million USD | -212.312% |
| iCAD, Inc. | -7.68 Million USD | -129.289% |
| Biotricity, Inc. | -8.82 Million USD | -99.699% |
| iRhythm Technologies, Inc. | -125.16 Million USD | 85.914% |
| Aethlon Medical, Inc. | -12.63 Million USD | -39.516% |
| InspireMD, Inc. | -21.14 Million USD | 16.615% |
| PAVmed Inc. | -68.79 Million USD | 74.373% |
| BIOLASE, Inc. | -17.93 Million USD | 1.712% |
| Beyond Air, Inc. | -63 Million USD | 72.019% |
| FONAR Corporation | 16.53 Million USD | 206.62% |
| AxoGen, Inc. | -21.46 Million USD | 17.855% |
| Vivani Medical, Inc. | -26.96 Million USD | 34.619% |
| Tactile Systems Technology, Inc. | 18.04 Million USD | 197.722% |
| Inari Medical, Inc. | -14.03 Million USD | -25.641% |
| UFP Technologies, Inc. | 57.66 Million USD | 130.574% |
| QT Imaging Holdings, Inc. | -4.92 Million USD | -257.781% |
| Heart Test Laboratories, Inc. | -6.3 Million USD | -179.585% |
| Tenon Medical, Inc. | -15.72 Million USD | -12.1% |
| Autonomix Medical, Inc. Common Stock | -7.47 Million USD | -135.884% |
| Co-Diagnostics, Inc. | -42.7 Million USD | 58.718% |
| AdaptHealth Corp. | -598.4 Million USD | 97.054% |
| Sintx Technologies, Inc. | -13.35 Million USD | -31.981% |
| NanoVibronix, Inc. | -3.43 Million USD | -413.097% |
| Quanterix Corporation | -49.7 Million USD | 64.528% |
| Inspira Technologies Oxy B.H.N. Ltd. | -12.13 Million USD | -45.306% |
| Sensus Healthcare, Inc. | -382 Thousand USD | -4515.183% |
| Pacific Biosciences of California, Inc. | -334.46 Million USD | 94.729% |
| TransMedics Group, Inc. | -28.72 Million USD | 38.629% |
| ReWalk Robotics Ltd. | -23.61 Million USD | 25.335% |
| NeuroMetrix, Inc. | -7.15 Million USD | -146.521% |
| Hyperfine, Inc. | -48.11 Million USD | 63.359% |
| Establishment Labs Holdings Inc. | -65.02 Million USD | 72.888% |
| Biomerica, Inc. | -6.36 Million USD | -176.896% |
| Bone Biologics Corporation | -9.42 Million USD | -86.99% |
| AVITA Medical, Inc. | -40.4 Million USD | 56.364% |
| Bluejay Diagnostics, Inc. | -10.31 Million USD | -70.979% |
| Silk Road Medical, Inc | -59.27 Million USD | 70.255% |